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2-1. DEHP???MEHP??????
DEHP??? MEHP????? Fig. 1???? ?
???? ??????????? ?Liquid Chromatog-
raphy; LC?-????????? ?Tandem mass spec-
trometer; MS/MS? ???? DEHP ??? MEHP ?
?????????? ?DEHP-d4 ??? MEHP-d4?
?????????????? ?????? ?????
???????? ?Electrospray ionization; ESI? ?
????? ?????????????????????
DEHP ?positive; m/z 391?149?? DEHP-d4 ?posi-
tive; m/z 395?153?? MEHP ?negative; m/z 277?
134?? MEHP-d4 ?negative; m/z 281?138? ????
??????????????? DEHP??????
?? ??????????????????? ????
??Mightysil® RP-18 GP ?5mm?2.0mm, 5m par-
ticle size? ?? ??????? Oasis® HLB extraction
column ?20mm?2.1mm, 25m particle size? ??
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MEHP-d4 (M.W.:  282)
DEHP-d4 (M.W.:  394)
MEHP  (M.W.:  278)
Figure 1. Chemical structures of DEHP, MEHP and
their surrogate compounds
Table 1 ? Drug additives in diluted drugs 
 noitartnecnoC sevitiddA sgurD
Glucose Nothing ? 
Prograf® Polyoxyethylated hydrogenated castor oil 
(HCO-60) 
80 fg/mL 
 nwonknU lonahte detardyheD 
Florid®  Lm/gμ 0001 06-OCH F-
Lastet® inj. Polyethylene glycol 400 (PEG-400) 240 μg/mL 
 Lm/gμ 23 )08 neewT( 08 etabrosyloP 
 nwonknU lonahtE 
 nwonknU dica cirtiC 
Table 2  Levels of DEHP and MEHP migrated into various drugs from PVC tubing 
Sample DEHP concentration (mean ± SD, μg/mL) 
 B ynapmoC A ynapmoC 
 60.0 ± 31.0 30.0 ± 21.0 esoculG
Prograf®  01.0 ± 04.4 71.0 ± 06.4 
Florid®  09.2 ± 46.45 36.3 ± 99.35 F-
Lastet® inj. 27.04 ± 0.62 28.88 ± 1.53 
   
Sample MEHP concentration (mean ± SD, μg/mL) 
 B ynapmoC A ynapmoC 
 00.0 ± 02.0 50.0 ± 65.0 esoculG
Prograf®  10.0 ± 21.0 40.0 ± 93.0 
Florid®  *DN *DN F-
Lastet®  *DN *DN .jni 
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?????????? ????????????????
????? 2-1???????? ???? 10L???
?? ?????????????????????? ?
????? ???? 5???? ???????????
????? HCO-60 ?0.02 mg/mL? ?????
???????? PVC???? 1 x 3??????
???????? 5mL??????????????
??? 37?? 1???????? ??????????
LC-MS/MS??????? PVC????? 10???
????????? ?????????? 8? ???
???? ??? 1??????????????? ?
?????????????? LC-MS/MS?????
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Table 3???? Fig. 2?????? ?????? 5
??????? DEHP????? ??????????
?? LOQ???????? ?ND?17.9 ng/mL?? ??




































X ??????? ?X-ray photoelectron spectros-
copy; XPS? ????? ????????? PVC??
????????????????????? ????
???? ?? X??monochromatic AlK?1,2? ?1486.6
eV?? X??? 1mm? ??????? 90??atom??
???? ????? Table 4?????? ??????
?? PVC???????? ?????? ??????
????????? ????????????????
???????? ?????????????????






????? ??????? ?Transmission electron
microscope; TEM? ????????
PVC ???????????????? ?Poly
methyl methacrylate; PMMA? ??????????







































































Figure 2. Levels of DEHP and MEHP migrated from
PVC sheet samples
(Mean? SD (ng/mL) ; n = 3 ; ND < 10 ng/mL (DEHP))
Table 3 Content of DEHP and MEHP in PVC sheet and tube samples 
 GOE evalcotuA yar-ammaG lortnoC  
Sheet DEHP (w/w %) 32.1 ± 5.7 27.8 ± 0.8 26.8 ± 1.6 26.8 ± 0.8 
 MEHP* (mg/g) ND 0.38 ± 0.05 ND ND 
Tube DEHP (w/w %) 44.7 ± 2.9 53.9 ± 2.5 ? ? 
 MEHP* (mg/g) ND ND (0.23) ? ? 
(Mean ± SD; n = 3; *one-hundredth dilution, ND < 0.25 mg/g (MEHP) 
 
 
Table 4 Surface constitution of sterilized PVC sheet (atom %) 
 nZ iS O lC C 
Control 71.9?1.22 2.0?0.29 14.7?0.40 11.4?0.56 <0.1 
Gamma-ray 71.5?0.20 1.7?0.26 15.0?0.12 11.8?0.12 ? 
Autoclave 71.3?0.17 2.2?0.06 14.6?0.17 11.9?0.25 ? 
EOG 72.0?0.25 2.0?0.25 14.6?0.30 11.2?0.29 <0.1 
The data are means and standard deviations obtained from triplicatemeasurement. 
 
?????? ?????????? ????? 100kV








2m? ???5mg??? ?????? X=1000???
? ?2m???? Y=250??? ?8m??? ????
?????? ???????? PVC?????????
?????? ?Ra :????????????????
????????? ?? 3.9?4.6m? ??????
?Rq :??????????????????????
?????? ?? 5.4?6.0m???? ???????
?????????? ?Fig. 3??
4-4. ???????????????????
?????? Nano Indenter XP????? ???
????????? ????????? ???? ???
????????????? ????? Fig. 4????
????????? PVC??????? ??????
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Figure 3. 3-D surface roughness measurement
KLA-Tencor P-15 contact stylus profiler was used to




















































Figure 4. Measurement of hardness and elastic
modulus
A) Schematic diagram of measurement principle
B) Typical load versus displacement curve
C) Formula of elastic modulus (E) and hardness (H)
*where and k are both constants. In the case of using
the berkovich tip, k = 24.56 and = 1.034.
Table 5? Elastic modulus (E) and hardness (H) of sterilized PVC sheet 
 Depth 1 μm Depth 5 μm Depth 20 μm 
E (MPa) H (MPa) E (MPa) H (MPa) E (MPa) H (MPa) 
Control 110?24 0.8 ?0.3  61?14 0.78?0.37 58? 8 1.1 ?0.2 
Gamma-ray 290?77 4.9 ?1.4  83?26 2.1 ?0.53 42?22 0.96?0.4 
Autoclave  85?18 0.39?0.31 40? 5 0.19?0.03 39? 6 0.52?0.09
EOG 100?32 0.74?0.31 47?11 0.47?0.34 40?11 0.66?0.1 
 

















DEHP ?positive; m/z 391?149?? MEHP ?negative;
m/z 277?134?? PA ?negative; m/z 165?121? ?
??? ????????? Table 6?????????
????????????
?????? PVC????? ??? ?0kGy? ??
? 1? 5? 10? 25? 50 kGy? 6??????? ???
???????25 kGy??
???????????? 0?50kGy???????
PVC??? ?1 x 3????? ?????? DEHP?
MEHP??? PA???????? ????? ????
5???? HCO-60????? Fig. 5????????
???? DEHP?? HCO-60???????? ???
??????????? ???????????????
??? MEHP??? PA??? ??????????
????????????? ??? HCO-60????
?? ???? 5???????????? ??????
? 25kGy????? PA?????????????
??????? ???? 25kGy? 50kGy ??? PVC
????????? ????????????????
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Intra-day (n=3) Inter-day (n=3) 




50 4.00 106.8                   8.68              100.6 




50 3.54 97.78 1.12 97.14 




50 4.37 99.97 1.58 98.87 
500 1.72 100.3                    0.28              100.6 




























































































Figure 5. Concentrations of DEHP, MEHP, and PA
that migrated from gamma-ray irradiated PVC sheet
Extraction solvents HCO-60, 5? glucose solution, and
water are represented by dark columns, white columns,
and gray columns, respectively.
 
Table 7 Elastic modulus and hardness  


















1 80 ± 17 0.42 ± 0.11 330 ± 120 2.9 ± 1.9 240 ± 140 2.0 ± 2.3 
5 59 ± 22 0.37 ± 0.22 180 ± 50 4.3 ± 2.3 130 ± 37 2.3 ± 2.3 
10 93 ± 35 1.1   ± 0.45 130 ± 21 3.6 ± 1.5 120 ± 19 2.2 ± 1.2 
20 130 ± 32 2.0 ± 0.56 100 ± 14 2.5 ± 0.7 100 ± 19 2.1 ± 0.6 
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Fig. 7 ??????®????????????? ?
?????????? DEHP??? TOTM???? ?
????????????? ??????? TOTM?
??? DEHP?????? ?????????? 24?




?? TOTM ? 9.02 g ?27.3w/w??? DEHP ? 14.52 g
?44.7w/w?? ? TOTM ??????? ??????
??????????????? 24????????










????????????? LC ?LC-UV? ???? ?
????????????????? TOTM ???













? ????????18????? ????? 24??
?????? TOTM??????????? ?Fig. 8??













Figure 7. The amount of migrated plasticizers into
Prograf®
























































1 hr UV irradiation
24 hrs UV irradiation
3 hrs UV irradiation
2hrs UV irradiation
TOTM






?? LC-????? ?Time of flight; TOF? -MS??
??? ?????????????????? ?????
5???????m/z 435.2753 ?mass error: 1.4 ppm?
????????????????? ?????
TOTM???????? 1????????????
















?????? ???? TOTM????? 10g/mL?
3??????? ???? 25kGy ?????? ????
??????????????? ????? LC-


































































5 % Glucose Prograf Sandimmun Florid-F
Unsterilized
Gamma-ray
Figure 9. Amount of TOTM migrating from PVC
tube into intravenous preparations
Each column represents the amount of TOTM ob-
tained from triplicate analysis (n = 3). Error bar repre-
sents standard deviation (S.D.). *Significantly different
from unsterilized control (p < 0.01) ; t-test. **Significantly
different from unsterilized control (p < 0.05) ; t-test.
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DEHP and alternative plasticizer migration from PVC medical device
Rie ITO
Department of Analytical Chemistry, Hoshi University
The risk assessment of di(2-ethylhexyl)phthalate (DEHP) and alternative plasticizer that migrate from polyvinyl chlo-
ride (PVC) medical devices is an important issue for patient. In order to study the migration of DEHP and its break-
down product, a method for the simultaneous determination of DEHP, MEHP, and phthalic acid (PA) was developed. In
the result, the levels of migration of DEHP from gamma-ray sterilized PVC or UV irradiated PVC were low compared
with those of the unsterilized/non-irradiated control. By contrast, the levels of MEHP migration were high. In the case
of gamma-ray irradiated PVC, not only MEHP but also PA was found to be the breakdown product of DEHP. The Min-
istry of Health, Labour and Welfare of Japan has recommended that alternatives be used to reduce DEHP exposure, es-
pecially for high-risk patients. Tris(2-ethylhexyl)trimellitate (TOTM), a trimellitate ester, is commonly used as an alter-
native plasticizer for medical devices in Japan. Therefore, TOTM migration was studied. Similarly to the DEHP
migration, the levels of migration of TOTM from gamma-ray sterilized PVC or UV irradiated PVC were low compared
with those of the unsterilized/non-irradiated control. In addition, the breakdown product of TOTM migrated from PVC
medical device was not almost observed in the chromatogram. The results demonstrate that TOTM is a superior alterna-
tive to DEHP for use in medical devices because of its lower leachability.
